KIORA PHARMACEUTICALS, INC. Other Receivables, Net, Current
KIORA PHARMACEUTICALS, INC. (KPRX) had Other Receivables, Net, Current of $0 as of 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Notes › Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2018-03-02
- 2017-12-31: Other Receivables, Net, Current $0.00.
- 2017-09-30: Other Receivables, Net, Current $602.00K.
- 2017-06-30: Other Receivables, Net, Current $146.08K.
- 2017-03-31: Other Receivables, Net, Current $109.83K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-02 |
| 2017-09-30 | $602.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $146.08K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $109.83K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $37.35K 10-K · filed 2018-03-02 |
| 2016-09-30 | $37.35K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $45.98K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $337.50K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $907.50K 10-K · filed 2017-02-23 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |